Legend Biotech LEGN
NASDAQ LEGN
$18.59 -0.04 (-0.21%)
As of: Oct 22, 2026 · 9:42 AM EDT

Legend Biotech (LEGN) EV to EBITDA (2023 - 2024)

Updated

Legend Biotech's EV to EBITDA was 52.70 in Q1 2025, up 315.1% from 12.70 a year earlier and up 258.2% from the prior quarter.

Analysis

Legend Biotech (LEGN) EV to EBITDA (2023 - 2024) Analysis & Trends

On a trailing twelve-month basis, Legend Biotech's EV to EBITDA was 16.36 through Mar 31, 2025, up 126.7% year-over-year; for FY2022, it was 15.40, up 6.8% from FY2021.

  • In earlier years, EV to EBITDA was 14.42 in FY2021 (+49.5%) and 9.64 in FY2020.
  • The Q1 2025 figure marks the highest quarterly EV to EBITDA since Q4 2022.
  • Compared with a year earlier, EV to EBITDA was higher in 1 of the last six quarters, with growth averaging 10.8%.
  • Per Business Quant data, LEGN's EV to EBITDA in the three quarters before Q1 2025 was 14.71 (Q4 2024), 12.94 (Q3 2024) and 8.11 (Q2 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,155.80 Bn 1,124.39 Bn 19.71 Bn
2 Johnson & Johnson 630.65 Bn 549.18 Bn 17.26 Bn
3 AbbVie 502.74 Bn 475.85 Bn 12.70 Bn
4 Merck 375.34 Bn 329.72 Bn 12.21 Bn
5 Novartis Ag 301.36 Bn 265.35 Bn 11.24 Bn
6 Astrazeneca 265.02 Bn 238.70 Bn 12.86 Bn
7 Amgen 239.16 Bn 194.55 Bn 7.24 Bn
8 Gilead Sciences 192.63 Bn 166.82 Bn 6.22 Bn
9 Pfizer 171.82 Bn 118.47 Bn 10.94 Bn
10 Legend Biotech 3.43 Bn 926.43 Mn 251.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 34.10
Mar 31, 2024 30.26
Dec 31, 2023 36.98
Sep 30, 2023 40.67
Jun 30, 2023 51.37
API Access

Legend Biotech EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=LEGN&period=max&api_key=YOUR_API_KEY